Drugplain

Nicotine transdermal system step 3 7 mg/24h

Nicotine · PATCH, EXTENDED RELEASE · Dr. Reddy's Laboratories Inc.

No Recall History
Plain English

Nicotine transdermal system step 3 is a patch, extended release containing nicotine at 7 mg/24h, taken transdermal. Manufactured by Dr. Reddy's Laboratories Inc..

Key Facts

Brand Name
Nicotine transdermal system step 3
Generic Name
Nicotine
NDC Code (Product)
43598-446
Manufacturer
Dr. Reddy's Laboratories Inc.
Strength
7 mg/24h
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Marketing Status
Application #
NDA020076
Drug Class
Cholinergic Nicotinic Agonist [EPC]
Marketing Start
05/14/2015

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective1,731 reports
nausea1,078 reports
product adhesion issue905 reports
overdose771 reports
headache759 reports
nicotine dependence752 reports
foetal exposure during pregnancy745 reports
treatment noncompliance679 reports
dyspnoea628 reports
pain626 reports

Frequently Asked Questions

What is Nicotine transdermal system step 3 used for?

Nicotine transdermal system step 3 contains Nicotine. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.

Is Nicotine transdermal system step 3 a controlled substance?

Nicotine transdermal system step 3 is not classified as a controlled substance by the DEA.

What is the generic name for Nicotine transdermal system step 3?

The generic name for Nicotine transdermal system step 3 is Nicotine. There are 12 other brand versions of Nicotine.

What is the NDC code for Nicotine transdermal system step 3 7 mg/24h?

The NDC (National Drug Code) for Nicotine transdermal system step 3 7 mg/24h is 43598-446, listed by Dr. Reddy's Laboratories Inc..